COMP <GO>
ZBH vs MSA // EV/EBITDA & P/E VALUATION
Zimmer Biomet Holdings Inc. (NYSE) VS. MSA Safety Incorporated (NYSE) • 15-METRIC TALLY: ZBH 7
— MSA 7
▲ EV/EBITDA & P/E VALUATION LEADER: MSA
LAST: $94.52 (-3.03%) • MKT CAP: $18.59B
valuation
19.3x
LAST: $178.57 (-0.33%) • MKT CAP: $6.91B
valuation
17.0x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ZBH VS. MSA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ZBH | MSA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 69.70% | 46.50% | +23.20 | ZBH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 4.60% | 16.60% | -12.00 | MSA | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 19.3x | 17.0x | +2.30 | MSA | /valuation <GO> |
| Free Cash Flow Yield | 7.92% | 4.27% | +3.65 | ZBH | /fcf-yield <GO> |
| Operating Margin | 13.30% | 19.80% | -6.50 | MSA | /operating-margins <GO> |
| Net Profit Margin | 8.60% | 14.90% | -6.30 | MSA | /net-margins <GO> |
| Revenue Growth (YoY) | 7.20% | 3.70% | +3.50 | ZBH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.02% | 1.19% | -0.17 | MSA | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.42 | 5.83 | -3.41 | MSA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | ZBH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 57.0 | 45.7 | +11.30 | ZBH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.02 | 0.87 | +0.15 | ZBH | /macro-sensitivity <GO> |
| Forward P/E Multiple | 24.6x | 23.1x | +1.50 | MSA | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $18.59B | $6.91B | $11.68B | ZBH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ZBH REV | MSA REV | ZBH GROSS % | MSA GROSS % | ZBH FCF | MSA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $8.23B | $1.87B | 69.7% | 46.5% | $1.47B | $295.4M |
| FY 2024 | $7.68B | $1.81B | 71.5% | 47.6% | $1.30B | $242.2M |
| FY 2023 | $7.39B | $1.79B | — | — | $1.25B | $12.4M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ZBH // BETA 1.02
MSA // BETA 0.87